2013-2028 Report on Global Antibody-drug Conjugates Market by Player, Region, Type, Application and Sales Channel


Report ID : RC-50494 Category : Pharmaceuticals
Published Date : Oct-19 Pages : 101 Format : PDF
The global Antibody-drug Conjugates market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Antibody-drug Conjugates from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Antibody-drug Conjugates market.

Leading players of Antibody-drug Conjugates including:
    ImmunoGen
    Seattle Genetics
    Roche
    Takeda
    ...

Market split by Type, can be divided into:
    Adcetris
    Kadcyla

Market split by Application, can be divided into:
    Breast Cancer
    Lymphoma

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Antibody-drug Conjugates Market Overview
    1.1 Antibody-drug Conjugates Definition
    1.2 Global Antibody-drug Conjugates Market Size Status and Outlook (2013-2028)
    1.3 Global Antibody-drug Conjugates Market Size Comparison by Region (2013-2028)
    1.4 Global Antibody-drug Conjugates Market Size Comparison by Type (2013-2028)
    1.5 Global Antibody-drug Conjugates Market Size Comparison by Application (2013-2028)
    1.6 Global Antibody-drug Conjugates Market Size Comparison by Sales Channel (2013-2028)
    1.7 Antibody-drug Conjugates Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Antibody-drug Conjugates Market Segment Analysis by Player
    2.1 Global Antibody-drug Conjugates Sales and Market Share by Player (2016-2018)
    2.2 Global Antibody-drug Conjugates Revenue and Market Share by Player (2016-2018)
    2.3 Global Antibody-drug Conjugates Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Antibody-drug Conjugates Market Segment Analysis by Type
    3.1 Global Antibody-drug Conjugates Market by Type
        3.1.1 Adcetris
        3.1.2 Kadcyla
    3.2 Global Antibody-drug Conjugates Sales and Market Share by Type (2013-2018)
    3.3 Global Antibody-drug Conjugates Revenue and Market Share by Type (2013-2018)
    3.4 Global Antibody-drug Conjugates Average Price by Type (2013-2018)
    3.5 Leading Players of Antibody-drug Conjugates by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Antibody-drug Conjugates Market Segment Analysis by Application
    4.1 Global Antibody-drug Conjugates Market by Application
        4.1.1 Breast Cancer
        4.1.2 Lymphoma
    4.2 Global Antibody-drug Conjugates Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Antibody-drug Conjugates by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Antibody-drug Conjugates Market Segment Analysis by Sales Channel
    5.1 Global Antibody-drug Conjugates Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Antibody-drug Conjugates Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Antibody-drug Conjugates by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Antibody-drug Conjugates Market Segment Analysis by Region
    6.1 Global Antibody-drug Conjugates Market Size and CAGR by Region (2013-2028)
    6.2 Global Antibody-drug Conjugates Sales and Market Share by Region (2013-2018)
    6.3 Global Antibody-drug Conjugates Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Antibody-drug Conjugates Market Share by Type
        6.4.3 North America Antibody-drug Conjugates Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Antibody-drug Conjugates Market Share by Type
        6.5.3 Europe Antibody-drug Conjugates Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Antibody-drug Conjugates Market Share by Type
        6.6.3 Asia-Pacific Antibody-drug Conjugates Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Antibody-drug Conjugates Market Share by Type
        6.7.3 South America Antibody-drug Conjugates Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Antibody-drug Conjugates Market Share by Type
        6.8.3 Middle East & Africa Antibody-drug Conjugates Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Antibody-drug Conjugates Players
    7.1 ImmunoGen
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Seattle Genetics
    7.3 Roche
    7.4 Takeda
Chapter 8 Upstream and Downstream Analysis of Antibody-drug Conjugates
    8.1 Industrial Chain of Antibody-drug Conjugates
    8.2 Upstream of Antibody-drug Conjugates
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Antibody-drug Conjugates
        8.3.1 Leading Distributors/Dealers of Antibody-drug Conjugates
        8.3.2 Leading Consumers of Antibody-drug Conjugates
Chapter 9 Development Trend of Antibody-drug Conjugates (2019-2028)
    9.1 Global Antibody-drug Conjugates Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Antibody-drug Conjugates Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

Sidebar Menu